denecimig   Click here for help

GtoPdb Ligand ID: 14697

Synonyms: Frehemgo® | MIM-8 | mim8 | NN-7769 | NN7769 | NNC-0365-3769 | NNC0365-3769
Compound class: Antibody
Comment: Denecimig (Mim8) is a bispecific antibody that functions as a factor VIII mimetic that bridges between Factor IXa and Factor X to promote clotting [1-4]. The FX-binding arm is engineered with low binding affinity to minimise target-mediated clearance, whilst the anti-FIXa arm binds more strongly and enhances the proteolytic activity of FIXa [1].
Click here for help
No information available.
Summary of Clinical Use Click here for help
Denecimig (Mim8) was progressed as a clinical candidate for the treatment of haemophilia A.
Clinical Trials
Clinical Trial ID Title Type Source Comment References
NCT05053139 A Research Study Investigating Mim8 in Adults and Adolescents With Haemophilia A With or Without Inhibitors Phase 3 Interventional Novo Nordisk A/S
NCT05306418 A Research Study Looking at Mim8 in Children With Haemophilia A With or Without Inhibitors Phase 3 Interventional Novo Nordisk A/S
NCT07830732 A Research Study Investigating Denecimig (Mim8) in Adults With Acquired Haemophilia A Phase 3 Interventional Novo Nordisk A/S